<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 22 Apr 2026 18:44:42 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/vaccinesmarketsize/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Vaccines Market | Statistical Analysis, Size, Share, and Forecast to 2023 By Top Key Players: GSK, Sanofi, Merck, Pfizer, Novartis(GSK)]]></title><description><![CDATA[Over the next five years, Vaccines will register a 6.2% CAGR in terms of revenue, reach US$ 50900 million by 2023, from US$ 35400 million in 2017. Global “Vaccines Market” peaks the detailed analysis of]]></description><link>http://direct.ecency.com/vaccinesmarketsize/@rachelzane/vaccines-market-or-statistical-analysis-size-share-and-forecast-to-2023-by-top-key-players-gsk-sanofi-merck-pfizer-novartis-gsk</link><guid isPermaLink="true">http://direct.ecency.com/vaccinesmarketsize/@rachelzane/vaccines-market-or-statistical-analysis-size-share-and-forecast-to-2023-by-top-key-players-gsk-sanofi-merck-pfizer-novartis-gsk</guid><category><![CDATA[vaccinesmarketsize]]></category><dc:creator><![CDATA[rachelzane]]></dc:creator><pubDate>Wed, 28 Nov 2018 12:02:45 GMT</pubDate></item></channel></rss>